# Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

> **NCT07269197** · — · COMPLETED · sponsor: **Josip Juraj Strossmayer University of Osijek** · enrollment: 67 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor

## Key facts

- **NCT ID:** NCT07269197
- **Lead sponsor:** Josip Juraj Strossmayer University of Osijek
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-22
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-10-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269197, "Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT07269197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*